Franklin Genomic Advancements ETF (HELX)

• Market cap: $9.99M
• 1 day: 0.00%
• 5 days: -8.58%
• 1 month: -11.80%
• 3 months: -14.65%
• 6 months: -10.36%
• Year to date: -7.31%
• 1 year: 3.59%
• 5 years: 19.16%
• 10 years: 19.16%

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

10.16% less ownership

Funds ownership: 26.05% [Q2] → 15.89% (-10.16%) [Q3]

25% less funds holding

Funds holding: 8 [Q2] → 6 (-2) [Q3]

38% less capital invested

Capital invested by funds: $2.48M [Q2] → $1.55M (-$931K) [Q3]

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3